Comparison of Family History and SNPs for Predicting Risk of Complex Disease

PLoS Genetics

Volumn 8, Issue 10, 2012, Pages

  Do, Chuong B ^a   Hinds, David A ^a   Francke, Uta ^a,b   Eriksson, Nicholas ^a  

^a 23andMe ^*  (United States)

^b STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACCURACY; ARTICLE; COMPLEX DISEASE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CROHN DISEASE; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; FAMILY HISTORY; GENDER; HERITABILITY; INTERMETHOD COMPARISON; MATHEMATICAL MODEL; PEDIGREE; PREDICTION; PREDICTIVE VALUE; QUANTITATIVE GENETICS; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SINGLE NUCLEOTIDE POLYMORPHISM;

FAMILY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LIKELIHOOD FUNCTIONS; MODELS, GENETIC; MULTIFACTORIAL INHERITANCE; PEDIGREE; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK; ROC CURVE;

EID: 84868256748     PISSN: 15537390     EISSN: 15537404     Source Type: Journal    
DOI: 10.1371/journal.pgen.1002973     Document Type: Article

References (53)

1. Hindorff LA, Sethupathy P, Junkins HA, Ramos EM, Mehta JP, et al.(2009) Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proc Natl Acad Sci USA 106: 9362-9367.
2. Manolio TA, Collins FS, Cox NJ, Goldstein DB, Hindorff LA, et al.(2009) Finding the missing heritability of complex diseases. Nature 461: 747-753.
3. Maher B, (2008) Personal genomes: The case of the missing heritability. Nature 456: 18-21.
4. Eichler EE, Flint J, Gibson G, Kong A, Leal SM, et al.(2010) Missing heritability and strategies for finding the underlying causes of complex disease. Nat Rev Genet 11: 446-450.
5. So HC, Gui AH, Cherny SS, Sham PC, (2011) Evaluating the heritability explained by known susceptibility variants: a survey of ten complex diseases. Genet Epidemiol 35: 310-317.
6. Guttmacher AE, Collins FS, Carmona RH, (2004) The family history-more important than ever. N Engl J Med 351: 2333-2336.
7. Yoon PW, Scheuner MT, Peterson-Oehlke KL, Gwinn M, Faucett A, et al.(2002) Can family history be used as a tool for public health and preventive medicine? Genet Med 4: 304-310.
8. Yoon PW, Scheuner MT, Jorgensen C, Khoury MJ, (2009) Developing Family Healthware, a family history screening tool to prevent common chronic diseases. Prev Chronic Dis 6: A33.
9. O'Neill SM, RubinsteinWS,Wang C, Yoon PW, Acheson LS, et al.(2009) Familial risk for common diseases in primary care: the Family Healthware Impact Trial. Am J Prev Med 36: 506-514.
10. Heald B, Edelman E, Eng C, (2012) Prospective comparison of family medical history with personal genome screening for risk assessment of common cancers. Eur J Hum Genet In press.
11. So HC, Kwan JS, Cherny SS, Sham PC, (2011) Risk prediction of complex diseases from family history and known susceptibility loci, with applications for cancer screening. Am J Hum Genet 88: 548-565.
12. Ruderfer DM, Korn J, Purcell SM, (2010) Family-based genetic risk prediction of multifactorial disease. Genome Med 2: 2.
13. Khoury MJ, Feero WG, Valdez R, (2010) Family history and personal genomics as tools for improving health in an era of evidence-based medicine. Am J Prev Med 39: 184-188.
14. Falconer DS, (1965) The inheritance of liability to certain diseases, estimated from the incidence among relatives. Annals of Human Genetics 29: 51-76.
15. Gail MH, Brinton LA, Byar DP, Corle DK, Green SB, et al.(1989) Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst 81: 1879-1886.
16. Wray NR, Yang J, Goddard ME, Visscher PM, (2010) The genetic interpretation of area under the ROC curve in genomic profiling. PLoS Genet 6: e1000864.
17. So HC, Sham PC, (2010) A unifying framework for evaluating the predictive power of genetic variants based on the level of heritability explained. PLoS Genet 6: e1001230.
18. Kohane IS, Masys DR, Altman RB, (2006) The incidentalome: a threat to genomic medicine. JAMA 296: 212-215.
19. Chen S, Parmigiani G, (2007) Meta-analysis of BRCA1 and BRCA2 penetrance. J Clin Oncol 25: 1329-1333.
20. Clayton DG, (2009) Prediction and interaction in complex disease genetics: experience in type 1 diabetes. PLoS Genet 5: e1000540.
21. Hall WD, Mathews R, Morley KI, (2010) Being more realistic about the public health impact of genomic medicine. PLoS Med 7: e1000347.
22. Roberts NJ, Vogelstein JT, Parmigiani G, Kinzler KW, Vogelstein B, et al.(2012) The predictive capacity of personal genome sequencing. Sci Transl Med 4: 133ra58.
23. Morton NE, MacLean CJ, (1974) Analysis of family resemblance. 3. Complex segregation of quantitative traits. Am J Hum Genet 26: 489-503.
24. Malone KE, Daling JR, Doody DR, Hsu L, Bernstein L, et al.(2006) Prevalence and predictors of BRCA1 and BRCA2 mutations in a population-based study of breast cancer in white and black American women ages 35 to 64 years. Cancer Res 66: 8297-8308.
25. Risch HA, McLaughlin JR, Cole DE, Rosen B, Bradley L, et al.(2001) Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer. Am J Hum Genet 68: 700-710.
26. Nussbaum RL, Ellis CE, (2003) Alzheimer's disease and Parkinson's disease. N Engl J Med 348: 1356-1364.
27. Hill WG, Goddard ME, Visscher PM, (2008) Data and theory point to mainly additive genetic variance for complex traits. PLoS Genet 4: e1000008.
28. Czene K, Lichtenstein P, Hemminki K, (2002) Environmental and heritable causes of cancer among 9.6 million individuals in the Swedish Family-Cancer Database. Int J Cancer 99: 260-266.
29. Lynch M, Walsh B (1998) Genetics and Analysis of Quantitative Traits. Sinauer.URL http://books.google.com/books?id=UhCCQgAACAAJ.
30. Falconer D (1989) Introduction to quantitative genetics. Longman, Scientific & Technical.URL http://books.google.com/books?id=on_wAAAAMAAJ.
31. Visscher PM, Hill WG, Wray NR, (2008) Heritability in the genomics era-concepts and misconceptions. Nat Rev Genet 9: 255-266.
32. Zuk O, Hechter E, Sunyaev SR, Lander ES, (2012) The mystery of missing heritability: Genetic interactions create phantom heritability. Proc Natl Acad Sci U S A In press.
33. Scheuner MT, Wang SJ, Raffel LJ, Larabell SK, Rotter JI, (1997) Family history: a comprehensive genetic risk assessment method for the chronic conditions of adulthood. Am J Med Genet 71: 315-324.
34. Yoon PW, Scheuner MT, Khoury MJ, (2003) Research priorities for evaluating family history in the prevention of common chronic diseases. Am J Prev Med 24: 128-135.
35. Ruffin MT, Nease DE, Sen A, Pace WD, Wang C, et al.(2011) Effect of preventive messages tailored to family history on health behaviors: the Family Healthware Impact Trial. Ann Fam Med 9: 3-11.
36. Ransohoff DF, Khoury MJ, (2010) Personal genomics: information can be harmful. Eur J Clin Invest 40: 64-68.
37. Qureshi N, Wilson B, Santaguida P, Carroll J, Allanson J, et al. (2007). Collection and use of cancer family history in primary care. Evidence Report/Technology Assessment No. 159 (prepared by the McMaster University Evidence-based Practice Center, under Contract No. 290-02-0020). AHRQ Publication No. 08-E001. Rockville, MD: Agency for Healthcare Research and Quality. October 2007.
38. Rubinstein WS, Acheson LS, O'Neill SM, Ruffin MT, Wang C, et al.(2011) Clinical utility of family history for cancer screening and referral in primary care: a report from the Family Healthware Impact Trial. Genet Med 13: 956-965.
39. Janssens AC, Moonesinghe R, Yang Q, Steyerberg EW, van Duijn CM, et al.(2007) The impact of genotype frequencies on the clinical validity of genomic profiling for predicting common chronic diseases. Genet Med 9: 528-535.
40. Bodmer W, Bonilla C, (2008) Common and rare variants in multifactorial susceptibility to common diseases. Nat Genet 40: 695-701.
41. Genz A, (1992) Numerical computation of multivariate normal probabilities. J Comp Graph Stat 1: 141-149.
42. Dudbridge F, Gusnanto A, (2008) Estimation of significance thresholds for genomewide association scans. Genet Epidemiol 32: 227-234.
43. 1000 Genomes Project Consortium(2010) A map of human genome variation from population-scale sequencing. Nature 467: 1061-1073.
44. Risch NJ, (2000) Searching for genetic determinants in the new millennium. Nature 405: 847-856.
45. Lohmueller KE, Pearce CL, Pike M, Lander ES, Hirschhorn JN, (2003) Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease. Nat Genet 33: 177-182.
46. Ghosh A, Zou F, Wright FA, (2008) Estimating odds ratios in genome scans: an approximate conditional likelihood approach. Am J Hum Genet 82: 1064-1074.
47. Dubois PC, Trynka G, Franke L, Hunt KA, Romanos J, et al.(2010) Multiple common variants for celiac disease influencing immune gene expression. Nat Genet 42: 295-302.
48. Franke A, McGovern DP, Barrett JC, Wang K, Radford-Smith GL, et al.(2010) Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci. Nat Genet 42: 1118-1125.
49. Barrett JH, Iles MM, Harland M, Taylor JC, Aitken JF, et al.(2011) Genome-wide association study identifies three new melanoma susceptibility loci. Nat Genet 43: 1108-1113.
50. Sawcer S, Hellenthal G, Pirinen M, Spencer CC, Patsopoulos NA, et al.(2011) Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature 476: 214-219.
51. Do CB, Tung JY, Dorfman E, Kiefer AK, Drabant EM, et al.(2011) Web-based genome-wide association study identifies two novel loci and a substantial genetic component for Parkinson's disease. PLoS Genet 7: e1002141.
52. Lanktree MB, Dichgans M, Hegele RA, (2010) Advances in genomic analysis of stroke: what have we learned and where are we headed? Stroke 41: 825-832.
53. Anderson CA, Boucher G, Lees CW, Franke A, D'Amato M, et al.(2011) Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47. Nat Genet 43: 246-252.